← Back to Search

Procedure

Focal Cryoablation for Prostate Cancer

Phase 2
Recruiting
Led By Justin Gregg, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through completion an average of 1 year.
Awards & highlights

Study Summary

This trial is testing whether using cryotherapy to treat only the part of the prostate containing cancer is effective in controlling prostate cancer.

Who is the study for?
Men with intermediate-risk prostate cancer who have a single focus of disease visible on MRI and confirmed by biopsy, without evidence of spread beyond the prostate. They must be able to undergo MRI, have not had previous treatments for prostate cancer or certain prostate surgeries, and are willing to follow study procedures.Check my eligibility
What is being tested?
The trial is testing focal cryotherapy, which freezes only the part of the prostate with cancer. It's compared against standard care. Participants will also complete quality-of-life questionnaires to assess how treatments affect their well-being.See study design
What are the potential side effects?
Focal cryotherapy may cause discomfort or pain at the treatment site, urinary issues like incontinence or irritation, sexual dysfunction, and potentially damage surrounding tissues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through completion an average of 1 year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and through completion an average of 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quality-of-life Questionnaires

Trial Design

1Treatment groups
Experimental Treatment
Group I: Focal therapy TreatmentExperimental Treatment3 Interventions
Cryoablation is a procedure in which special needles are inserted into the tumor site.

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,973 Previous Clinical Trials
1,789,291 Total Patients Enrolled
95 Trials studying Prostate Cancer
29,710 Patients Enrolled for Prostate Cancer
Philanthropic SourcesUNKNOWN
Justin Gregg, MDPrincipal Investigatorjrgregg@mdanderson.org

Media Library

Focal Cryoablation (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05454488 — Phase 2
Prostate Cancer Research Study Groups: Focal therapy Treatment
Prostate Cancer Clinical Trial 2023: Focal Cryoablation Highlights & Side Effects. Trial Name: NCT05454488 — Phase 2
Focal Cryoablation (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05454488 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been enrolled in this experiment thus far?

"Affirmative. According to information from clinicaltrials.gov, this medical experiment is currently recruiting volunteers and was first made accessible on July 25th 2022. The most recent amendment occurred on November 16th 202022 with a target of 30 participants for the single site."

Answered by AI

Does this research require additional volunteers?

"Affirmative. Per the information hosted on clinicaltrials.gov, this medical trial is recruiting participants as of now. It was first posted on July 25th 2022 and most recently updated two months ago on November 16th 2022; it requires 30 patients from one site to be enrolled in order for the study to proceed."

Answered by AI

Has Focal Cryoablation obtained approval from the Food and Drug Administration?

"Focal Cryoablation has proven safe in Phase 2 clinical trials, thus garnering a score of 2. However, there is not yet any evidence regarding its efficacy."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
MD Anderson Cancer Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
2022. "An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05454488.
All > Mens Health
~15 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top